Hamburg has more than 2,000 bridges.

Which makes ESGCT a fitting spot to connect with the ideal manufacturing partner.

Booths F01 + F08 | Hamburg, Germany | October 27-30, 2026

Gene and cell therapy innovators from around the world will gather at ESGCT 2026 to solidify the connections that drive the future of cell and gene therapy. We’ll be right there – in Booths F01 + F08, to be exact – helping AAV innovators discover how they can take on their toughest manufacturing challenges with our exclusive Aava™ platform. From early stage development to late-stage commercial scale up, Aava™ was built to deliver on the promise of worry-free manufacturing.

Why Aava™

text (2)
Better Foresight: Leverage 2,000+ batches’ worth of data to signal early predictability of your construct.
icon_space ship 1
Superior Speed: Scale faster from research to clinical to commercial while reducing PD and validation timelines.
Group 2

Deeper Data: Simplify and de-risk your registration process through access to our CMC package and data management.

text (1)

Proven Delivery: Trust the team that has a 100% success rate with IND/IMPD dossiers.

Schedule a Meeting

Say hello to

Aava wordmark white

 

The version of Aava™ that’s right for you depends on your drivers: If speed and stability are top-of-mind, Mendi is a great choice; if scale and efficiency are the priority, Iturri may be the better fit. Either way, Aava™ can be adapted to fit your specific needs, so you can achieve your manufacturing goals. Start by learning more here.

Connect with everything AAV: learn more here
All the Pieces Fit – and All the Pieces Matter: An Update on Holistic CSR with Viralgen CEO Jimmy Vanhove
All the Pieces Fit – and All the Pieces Matter: An Update on Holistic CSR with Viralgen CEO Jimmy Vanhove
A 2025 analysis published in the International Journal of Financial Studies drew a clear, direct correlation between corporate social responsibility (CSR) and performance: Put simply, companies that win in CSR outperform their peers. It’s a business...
READ MORE
July 27, 2026
Supporting Innovation Through AAV Manufacturing: A Visit from Donostia Mayor
Supporting Innovation Through AAV Manufacturing: A Visit from Donostia Mayor
The visit of Donostia / San Sebastián Mayor Jon Insausti to Viralgen was an opportunity to open our doors and share, once again, what we do and why it matters: supporting the development and manufacturing of AAV-based gene therapies that aim to...
READ MORE
July 10, 2026
Viralgen @ ASGCT: What We Saw, What To Keep An Eye On
Viralgen @ ASGCT: What We Saw, What To Keep An Eye On
ASGCT in Boston was, as always, packed with people, posters, innovations, and insights. It’s an exciting time, and a great opportunity to reconnect with peers and discover great science. Now that the Viralgen team has had a chance to share notes and...
READ MORE
June 01, 2026